Zacks Research Brokers Boost Earnings Estimates for TSE:BHC

Key Points

• Zacks Research has raised its earnings estimates for Bausch Health Companies, now forecasting $1.52 per share for Q3 2025, an increase from the previous estimate of $1.51.
• The company's current full-year earnings estimate stands at $5.55 per share, with additional projections for future quarters also released.
• Bausch Health Companies has a market cap of C$3.34 billion and is currently trading at C$9.04, with a 12-month trading range of C$5.91 to C$13.74.

Bausch Health Companies Inc. (TSE:BHC - Free Report) - Stock analysts at Zacks Research upped their Q3 2025 earnings per share estimates for Bausch Health Companies in a report released on Friday, September 26th. Zacks Research analyst Team now forecasts that the company will post earnings of $1.52 per share for the quarter, up from their prior estimate of $1.51. The consensus estimate for Bausch Health Companies' current full-year earnings is $5.55 per share. Zacks Research also issued estimates for Bausch Health Companies' Q3 2026 earnings at $1.62 EPS, Q4 2026 earnings at $1.59 EPS, Q1 2027 earnings at $1.22 EPS and FY2027 earnings at $6.11 EPS.

Bausch Health Companies Trading Up 0.3%

TSE:BHC opened at C$9.04 on Monday. The firm has a market cap of C$3.34 billion, a PE ratio of 34.77, a price-to-earnings-growth ratio of 0.21 and a beta of 0.48. The stock has a fifty day moving average price of C$9.54 and a 200 day moving average price of C$8.39. Bausch Health Companies has a 12-month low of C$5.91 and a 12-month high of C$13.74. The company has a current ratio of 1.19, a quick ratio of 0.58 and a debt-to-equity ratio of -1,831.94.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.